What Researchers Did
Researchers calculated the direct costs of monoplace hyperbaric oxygen therapy (HBOT) for inpatients using a single chamber, including equipment, staff, oxygen, property, and overheads.
What They Found
Start-up costs for monoplace hyperbaric oxygen therapy ranged from £64,800 to £110,000, depending on hardware selection. Annual costs, including 10-year amortisation, were between £40,069 and £57,618, leading to per-treatment costs of £30 to £41. Oxygen recirculation became cost-effective after four to six years of operation.
Canadian Relevance
This study has no direct Canadian connection as it was conducted within the UK NHS system.
Study Limitations
The study's findings are based on cost data from 2004 within the UK NHS, which may not directly translate to current costs or other healthcare systems.